APA (7th ed.) Citation

Valero-Arrese, L., Doz, F., Nysom, K., Sjöberg Bexelius, T., Idbaih, A., Geoerger, B., . . . Perreault, S. (2025). 664MO Long-term efficacy and safety of larotrectinib in TRK fusion primary central nervous system tumours: An updated analysis. Annals of Oncology, 36, S484. https://doi.org/10.1016/j.annonc.2025.08.1239

Chicago Style (17th ed.) Citation

Valero-Arrese, L., et al. "664MO Long-term Efficacy and Safety of Larotrectinib in TRK Fusion Primary Central Nervous System Tumours: An Updated Analysis." Annals of Oncology 36 (2025): S484. https://doi.org/10.1016/j.annonc.2025.08.1239.

MLA (9th ed.) Citation

Valero-Arrese, L., et al. "664MO Long-term Efficacy and Safety of Larotrectinib in TRK Fusion Primary Central Nervous System Tumours: An Updated Analysis." Annals of Oncology, vol. 36, 2025, p. S484, https://doi.org/10.1016/j.annonc.2025.08.1239.